跳至主要内容
临床试验/IRCT20190321043096N1
IRCT20190321043096N1已完成3 期

Evaluation of the Effect of Ondansetron as Additional Drug on Reducing Negative Symptoms in Hospitalized and Outpatient with Schizophrenia Disorders

Gorgan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • age of 18-65
  • No physical illness
  • No alcohol or drug abuse
  • The absence of pregnancy and lactation in women
  • PANSS score of more than 15
  • Acceptance of written consent

排除标准

  • Drug abuse or alcohol abuse
  • Breastfeeding and pregnancy women
  • The need for other psychotropic drugs during the study

研究者

发起方
Gorgan University of Medical Sciences

相似试验